Drugs Can Help Heart Patients Fight Infection
Posted on: Wednesday, 25 January 2006, 12:00 CST
CHOLESTEROL-lowering drugs can reduce the risk of an often fatal condition in heart disease patients caused by infection, new research has shown.
The drugs, called statins, are widely used to prevent atherosclerosis, the furring up and narrowing of arteries.
Earlier animal studies suggested that they might also help prevent sepsis, a condition brought on by overwhelming infection that can cause the failure of multiple organs, including the heart, lungs and kidneys.
Researchers led by Dr Donald Redelmeier, from Sunnybrook & Women's Hospital in Ontario, Canada, analysed data from more than 69,000 people aged over 65 with heart and artery disease.
All were patients who had been hospitalised. Half were prescribed statins when discharged, and half were not.
The findings showed that, after two years, 551 patients were re- admitted to hospital for sepsis in the statin group, compared with 667 in the other group, a difference of 19%.
Dr Redelmeier said: "The use of statins in patients with atherosclerosis was associated with a significantly reduced risk of sepsis, including severe sepsis and fatal sepsis."
Source: Daily Post; Liverpool
Related Articles
- Improving Treatment Of Patients With Heart Attack
- Crowded Emergency Clinics Pose Greater Risks For Patients With Heart Attacks
- Studies Indicate Exercise Training Could Provide Some Benefit For Patients With Heart Failure
- Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
- Lipitor 80 Mg Provided Sustained Risk Reduction of Cardiovascular Events in Patients With Heart Disease During the Five-Year TNT Trial
- Lipitor 80 Mg Reduced the Risk of Heart Attack and Stroke in Patients With Heart Disease, Type 2 Diabetes and Chronic Kidney Disease
- Patients With Heart Conditions Can Benefit From New Delta Dental Coverage
- CoGenesys Initiates Phase 1-2 Clinical Trial of Cardeva in Patients With Heart Failure
- US patients with heart failure have better short-term survival rates than Canadian patients
- Amgen Announces Initiation of Phase 3 Trial to Evaluate the Impact of Treating Anemia With Darbepoetin Alfa in Patients With Heart Failure to Reduce Mortality and Hospitalization
 |
 |
User Comments (0)
RSS Feeds